Alle verbonden artikelen

Mesenchymal stromal cells from the foreskin: Tissue isolation, cell characterization and immunobiological properties.

Auteurs : Najar M, Raicevic G, André T, Fayyad-Kazan H, Pieters K, Bron D, Toungouz M, Lagneaux L
Jaar : 2016
Journal : Cytotherapy
Volume : 18
Pagina's : 320-35

The Immunomodulatory Potential of Mesenchymal Stromal Cells: A Story of a Regulatory Network.

Auteurs : Najar M, Raicevic G, Crompot E, Fayyad-Kazan H, Bron D, Toungouz M, Lagneaux L
Jaar : 2016
Journal : J Immunother
Volume : 39
Pagina's : 45-59

Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells.

Auteurs : Najar M, Raicevic G, Fayyad-Kazan H, Bron D, Toungouz M, Lagneaux L
Jaar : 2016
Journal : Cytotherapy
Volume : 18
Pagina's : 160-71

Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells.

Auteurs : Mittal D, Caramia F, Michiels S, Joensuu H, Kellokumpu-Lehtinen PL, Sotiriou C, Loi S, Smyth MJ
Jaar : 2016
Journal : Cancer Res
Volume : 76
Pagina's : 264-74

The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.

Auteurs : Ignatiadis M, Azim HA Jr, Desmedt C, Veys I, Larsimont D, Salgado R, Lyng MB, Viale G, Leyland-Jones B, Giobbie-Hurder A, Kammler R, Dell orto P, Rothé F, Laïos I, Ditzel HJ, Regan MM, Piccart-Gebhart M, Michiels S, Sotiriou C
Jaar : 2016
Journal : JAMA Oncol
Volume : 2(2)
Pagina's : 217-24

Onco-haematology geriatry : impact of cognitive disorders.

Auteurs : Dubruille S, Libert Y, Razavi D, Bron D
Jaar : 2016
Journal : Belgian J Hematology
Volume : 7
Pagina's : 180-3

Belgium recommendations for the management of acute promyelocytic leukaemia

Auteurs : Wittnebel S
Jaar : 2016
Journal : Belgian J Hematology
Volume : 7
Pagina's : 224-8

BHS guidelines for the treatment of large granular lymphocyte and cronic prolymphocytic leukaemias

Auteurs : Delrieu V, Wu KL, Schroyens W, Bonnet C, Bron D, Janssens A
Jaar : 2016
Journal : Belgian J Hematology
Volume : 7
Pagina's : 103-11

Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance.

Auteurs : Van Damme M, Crompot E, Meuleman N, Maerevoet M, Mineur P, Bron D, Lagneaux L, Stamatopoulos B
Jaar : 2016
Journal : Clin Epigenetics
Volume : 8
Pagina's : 132

Costs of haematological disease high and rising.

Auteurs : Green T, Bron D, Chomienne C, de Wit TD, de Haas F, Engert A, Hagenbeek A, Jäger U, MacIntyre E, Muckenthaler MU, Smand C, Sonneveld P
Jaar : 2016
Journal : Lancet Haematol
Volume : 3
Pagina's : e353-4

Diagnosis of congenital von Willebrand disease during a preoperative assessment in a multiple myeloma patient without bleeding history.

Auteurs : El Ouaaliti M, Li R, Gobin D, Bron D, Cantinieaux B
Jaar : 2016
Journal : Clin Case Rep
Volume : 4
Pagina's : 703-6

The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor gene.

Auteurs : Van Kempen LC, Redpath M, Elchebly M, Klein KO, Papadakis AI, Wilmott JS, Scolyer RA, Edqvist PH, Pontén F, Schadendorf D, van Rijk AF, Michiels S, Dumay A, Helbling-Leclerc A, Dessen P, Wouters J, Stass M, Greenwood CM, Ghanem G, van den Oord J, Feunteun J, Spatz A
Jaar : 2016
Journal : Sci Transl Med
Volume : 8
Pagina's : 369ra177

Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group.

Auteurs : Denkert C, Wienert S, Poterie A, Loibl S, Budczies J, Badve S, Bago-Horvath Z, Bane A, Bedri S, Brock J, Chmielik E, Christgen M, Colpaert C, Demaria S, Van den Eynden G, Floris G, Fox SB, Gao D, Ingold Heppner B, Kim SR, Kos Z, Kreipe HH, Lakhani SR, Penault-Llorca F, Pruneri G, Radosevic-Robin N, Rimm DL, Schnitt SJ, Sinn BV, Sinn P, Sirtaine N, OToole SA, Viale G, Van de Vijver K, de Wind R, Von Minckwitz G, Klauschen F, Untch M, Fasching PA, Reimer T, Willard-Gallo K, Michiels S, Loi S, Salgado R
Jaar : 2016
Journal : Mod Pathol
Volume : 29(10)
Pagina's : 1155-64

Severe Prolonged Cough as Presenting Manifestation of FIP1L1-PDGFRA+ Chronic Eosinophilic Leukaemia: A Widely Ignored Association.

Auteurs : Roufosse F, Heimann P, Lambert F, Sidon P, Bron D, Cottin V, Cordier JF
Jaar : 2016
Journal : Respiration
Volume : 91
Pagina's : 374-9

Opposite prognostic significance of cellular and serum circulating microRNA-150 in Chronic Lymphocytic Leukemia patients.

Auteurs : Stamatopoulos B, Van Damme M, Crompot E, Dessars B, El Housni H, Mineur P, Meuleman N, Bron D, Lagneaux L
Jaar : 2015
Journal : Mol. Med.
Volume : 21(1)
Pagina's : 123-33

Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin's lymphoma.

Auteurs : Czuczman MS, Kahanic S, Forero A, Davis G, Munteanu M, Van Den Neste E, Offner F, Bron D, Quick D, Fowler N
Jaar : 2015
Journal : Ann Hematol
Volume : 94(4)
Pagina's : 633-41

In vivo characterizatio of the BLV miRNA cluster

Auteurs : Rodari A, Van Driessche B, Delacourt N, Vanhulle C, Burny A, Van den Broeke A, Rohr O, Van Lint C
Jaar : 2015
Journal : Retrovirology
Volume : 12(1
Pagina's : 11

Circadian and circannual variations in cord blood hematopoietic cell composition.

Auteurs : Servais S, Baudoux E, Brichard B, Bron D, Debruyn C, De Hemptinne D, Deneys V, Paulus JM, Schaaps JP, Van Cauwenberge JR, Seidel L, Delforge A, Beguin Y
Jaar : 2015
Journal : Haematologica
Volume : 100(1)
Pagina's : 32-34

Bone Marrow Mesenchymal Stromal Cells Induce Proliferative, Cytokinic and Molecular Changes During the T Cell Response: The Importance of the IL-10/CD210 Axis.

Auteurs : Najar M, Raicevic G, Fayyad-Kazan H, De Bruyn C, Bron D, Toungouz M, Lagneaux L
Jaar : 2015
Journal : Stem Cell Rev
Volume : 11(3)
Pagina's : 442-52

Immune impairments in multiple myeloma bone marrow mesenchymal stromal cells.

Auteurs : André T, Najar M, Stamatopoulos B, Pieters K, Pradier O, Bron D, Meuleman N, Lagneaux L
Jaar : 2015
Journal : Cancer Immunol Immunother
Volume : 64(2)
Pagina's : 213-24